Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
VANI Vivani Medical Inc
- Stocks
- Healthcare
- NASDAQ: VANI
Price (delayed)
$1.12
Market cap
$66.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.43
Enterprise value
$69.64M
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in
Highlights
The debt has decreased by 13% YoY
The EPS is up by 12% year-on-year
The equity has plunged by 60% YoY and by 34% from the previous quarter
The company's quick ratio has shrunk by 54% YoY and by 30% QoQ
Key stats
What are the main financial stats of VANI
Market
Valuations
Earnings
Shares outstanding
59.24M
Market cap
$66.35M
Enterprise value
$69.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.71
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$25.01M
Net income
-$23.75M
EBIT
-$23.75M
EBITDA
-$23.09M
Free cash flow
-$21.82M
Per share
Balance sheet
Liquidity
EPS
-$0.43
EPS diluted
-$0.43
Free cash flow per share
-$0.37
Book value per share
$0.2
Revenue per share
$0
TBVPS
$0.6
Total assets
$35.45M
Total liabilities
$23.83M
Debt
$17.63M
Equity
$11.62M
Working capital
$8.65M
Debt to equity
1.52
Current ratio
2.4
Quick ratio
2.31
Net debt/EBITDA
-0.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-56.5%
Return on equity
-133.1%
Return on invested capital
-68.9%
Return on capital employed
-81.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VANI stock price
How has the Vivani Medical stock price performed over time
Intraday
-1.75%
1 week
-1.75%
1 month
7.69%
1 year
-31.71%
YTD
-3.45%
QTD
6.67%
Financial performance
How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.01M
Net income
-$23.75M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has increased by 6% YoY
VANI's operating income is up by 6% YoY
Price vs fundamentals
How does VANI's price correlate with its fundamentals
Growth
What is Vivani Medical's growth rate over time
Valuation
What is Vivani Medical stock price valuation
P/E
N/A
P/B
5.71
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 12% year-on-year
The equity has plunged by 60% YoY and by 34% from the previous quarter
VANI's price to book (P/B) is 46% more than its last 4 quarters average of 3.9 but 8% less than its 5-year quarterly average of 6.2
Efficiency
How efficient is Vivani Medical business performance
The return on equity has declined by 42% year-on-year and by 25% since the previous quarter
The return on assets has declined by 18% year-on-year and by 12% since the previous quarter
Vivani Medical's return on invested capital has decreased by 5% YoY and by 4.4% QoQ
Dividends
What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VANI.
Financial health
How did Vivani Medical financials performed over time
The total assets is 49% more than the total liabilities
The company's quick ratio has shrunk by 54% YoY and by 30% QoQ
Vivani Medical's current ratio has shrunk by 53% YoY and by 30% QoQ
The debt is 52% higher than the equity
VANI's debt to equity has surged by 114% year-on-year and by 49% since the previous quarter
The equity has plunged by 60% YoY and by 34% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.